透析患者中心静脉狭窄或闭塞的腔内治疗进展
Progress of Endovascular Treatment for Central Venous Stenosis or Occlusion in Hemodialysis Patients
DOI: 10.12677/acm.2025.1551420, PDF,   
作者: 李新宇*, 付利锋, 陈居正:赣南医科大学第一临床医学院,江西 赣州;方萃福#:赣南医科大学第一附属医院血管外科,江西 赣州
关键词: 血液透析中心静脉狭窄腔内治疗血管Hemodialysis Central Venous Stenosis Endovascular Treatment Vascular
摘要: 中心静脉疾病是维持性血液透析患者血管通路的严重并发症之一,以中心静脉狭窄或闭塞(Central venous stenosis/occlusion, CVS/O)为主要病理表现。CVS/O可通过引发静脉高压综合征破坏血管通路完整性,显著降低透析充分性并缩短患者总体透析龄。目前,以经皮腔内血管成形术(Percutaneous transluminal angioplasty, PTA)及支架置入术(Stent placement)为核心的血管内介入治疗已成为临床一线治疗方案。尽管腔内治疗能有效恢复短期静脉通畅性并改善通路功能,但术后再狭窄问题仍严重影响远期疗效。本文系统综述CVS/O腔内治疗的技术进展与循证证据,探讨现存挑战及未来研究方向。
Abstract: Central venous disease, manifesting as stenosis or occlusion (CVS/O), represents a critical complication of vascular access in hemodialysis patients. CVS/O can induce severe venous hypertension, compromise vascular access integrity, reduce dialysis adequacy, and shorten overall dialysis vintage. Endovascular interventions, including percutaneous transluminal angioplasty (PTA) and stent placement, are currently first-line therapies. While these minimally invasive approaches effectively restore short-term venous patency and improve access functionality, the persistent challenge of restenosis significantly compromises long-term outcomes. This review synthesizes recent technological advancements and evidence-based practices in endovascular management of CVS/O, while addressing current limitations and future directions.
文章引用:李新宇, 付利锋, 陈居正, 方萃福. 透析患者中心静脉狭窄或闭塞的腔内治疗进展[J]. 临床医学进展, 2025, 15(5): 668-673. https://doi.org/10.12677/acm.2025.1551420

参考文献

[1] Bello, A.K., Okpechi, I.G., Levin, A., et al. (2024) An Update on the Global Disparities in Kidney Disease Burden and Care across World Countries and Regions. The Lancet Global Health, 12, e382-e395.
[2] Johansen, K.L., Chertow, G.M., Gilbertson, D.T., Herzog, C.A., Ishani, A., Israni, A.K., et al. (2022) US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases, 79, A8-A12. [Google Scholar] [CrossRef] [PubMed]
[3] Al-Balas, A., Almehmi, A., Varma, R., Al-Balas, H. and Allon, M. (2022) De Novo Central Vein Stenosis in Hemodialysis Patients Following Initial Tunneled Central Vein Catheter Placement. Kidney360, 3, 99-102. [Google Scholar] [CrossRef] [PubMed]
[4] Adwaney, A., Lim, C., Blakey, S., Duncan, N. and Ashby, D.R. (2019) Central Venous Stenosis, Access Outcome and Survival in Patients Undergoing Maintenance Hemodialysis. Clinical Journal of the American Society of Nephrology, 14, 378-384. [Google Scholar] [CrossRef] [PubMed]
[5] Echefu, G., Stowe, I., Lukan, A., Sharma, G., Basu-Ray, I., Guidry, L., et al. (2023) Central Vein Stenosis in Hemodialysis Vascular Access: Clinical Manifestations and Contemporary Management Strategies. Frontiers in Nephrology, 3, Article ID: 1280666. [Google Scholar] [CrossRef] [PubMed]
[6] 金其庄, 王玉柱, 叶朝阳, 等. 中国血液透析用血管通路专家共识(第2版) [J]. 中国血液净化, 2019, 18(6): 365-381.
[7] Lok, C.E., Huber, T.S., Lee, T., Shenoy, S., Yevzlin, A.S., Abreo, K., et al. (2020) KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases, 75, S1-S164. [Google Scholar] [CrossRef] [PubMed]
[8] 国家卫生健康委办公厅关于印发冠状动脉球囊成形术与支架植入术操作规范(2022年版)和髋膝关节置换术操作规范(2022年版)的通知[Z].
[9] 詹申, 赵彬, 王慧, 等. 外周切割球囊治疗动静脉内瘘长段狭窄的疗效及治疗后再狭窄的影响因素[J]. 中华肾脏病杂志, 2024, 40(7): 533-539.
[10] Pang, S., Chang, T., Chang, M., Huang, X., Wang, X., Song, M., et al. (2024) Efficacy of Cutting Balloon Angioplasty versus High-Pressure Balloon Angioplasty for the Treatment of Arteriovenous Fistula Stenoses in Patients Undergoing Hemodialysis: Systematic Review and Meta-Analysis. PLOS ONE, 19, e0296191. [Google Scholar] [CrossRef] [PubMed]
[11] Tan, Z., Chan, S.X.J.M., Da Zhuang, K., Urlings, T., Leong, S., Chua, J.M.E., et al. (2022) Recurrent Stenoses in Arteriovenous Fistula (AVF) for Dialysis Access: Cutting Balloon Angioplasty Combined with Paclitaxel Drug-Coated Balloon Angioplasty, an Observational Study (INSTITUTION Study). CardioVascular and Interventional Radiology, 45, 646-653. [Google Scholar] [CrossRef] [PubMed]
[12] Chong, T.T., Yap, H.Y., Tan, C.S., Lee, Q.S., Chan, S.L., Wee, I.J.Y., et al. (2020) Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit? Vascular Specialist International, 36, 21-27. [Google Scholar] [CrossRef] [PubMed]
[13] Dariushnia, S.R., Walker, T.G., Silberzweig, J.E., Annamalai, G., Krishnamurthy, V., Mitchell, J.W., et al. (2016) Quality Improvement Guidelines for Percutaneous Image-Guided Management of the Thrombosed or Dysfunctional Dialysis Circuit. Journal of Vascular and Interventional Radiology, 27, 1518-1530. [Google Scholar] [CrossRef] [PubMed]
[14] Wu, T., Wu, C., Chen, Y. and Lin, C. (2020) Comparison of Percutaneous Transluminal Angioplasty with Stenting for Treatment of Central Venous Stenosis or Occlusion in Hemodialysis Patients: A Systematic Review and Meta-Analysis. CardioVascular and Interventional Radiology, 43, 525-540. [Google Scholar] [CrossRef] [PubMed]
[15] 任莉, 郭烁. 经皮球囊血管成形术与经皮支架植入术治疗透析患者中心静脉狭窄的有效性及安全性比较[J]. 临床医学研究与实践, 2024, 9(5): 71-75.
[16] Kavan, J., Kudlicka, J., Malik, J., Chytilova, E., Lambert, L., Slavikova, M., et al. (2019) Treatment of Failing Arterio-Venous Dialysis Graft by Angioplasty, Stent, and Stent Graft: Two-Years Analysis of Patency Rates and Cost-Effectiveness. Experimental and Therapeutic Medicine, 18, 4144-4150. [Google Scholar] [CrossRef] [PubMed]
[17] 郭辉, 刘佳妮, 张永裕, 等. 经皮腔内支架植入术治疗中心静脉狭窄29例分析[J]. 中华介入放射学电子杂志, 2020, 8(2): 108-113.
[18] Chen, B., Lin, R., Dai, H., Yang, J., Tang, K., Li, N., et al. (2022) One-Year Outcomes and Predictive Factors for Primary Patency after Stent Placement for Treatment of Central Venous Occlusive Disease in Hemodialysis Patients. Therapeutic Advances in Chronic Disease, 13. [Google Scholar] [CrossRef] [PubMed]
[19] Shintaku, S., Sato, T., Kawanishi, H., Moriishi, M. and Tsuchiya, S. (2018) The Efficacy of Drug-Eluting Stent for Recurrent Central Venous Restenosis in a Patient Undergoing Hemodialysis. The Journal of Vascular Access, 20, 76-79. [Google Scholar] [CrossRef] [PubMed]
[20] Xiong, Y., Tu, B., Zhang, M., Chen, B., Lai, Q., Chen, J., et al. (2024) Case Report: A Case of Rapamycin-Eluting Stent for the Treatment of Refractory Stenosis of Arteriovenous Fistula Stenosis. Frontiers in Cardiovascular Medicine, 11, Article ID: 1449989. [Google Scholar] [CrossRef] [PubMed]
[21] Merinopoulos, I., Gunawardena, T., Corballis, N., Bhalraam, U., Reinhold, J., Wickramarachchi, U., et al. (2023) Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI. JACC: Cardiovascular Interventions, 16, 771-779. [Google Scholar] [CrossRef] [PubMed]
[22] Tabriz, D.M. and Arslan, B. (2022) Hero Graft: Indications, Technique, Outcomes, and Secondary Intervention. Seminars in Interventional Radiology, 39, 82-89. [Google Scholar] [CrossRef] [PubMed]
[23] Sur, B., Baran, T., Foster, T., Wilson, I. and Sasson, T. (2017) Management of Central Venous Stenosis in Hemodialysis Patients: Comparison of Outcomes with the Hemodialysis Reliable Outflow (HeRO) Graft versus Stenting. Journal of Vascular and Interventional Radiology, 28, S63. [Google Scholar] [CrossRef
[24] Proksch, D.M., Rodriguez, L.E., Rathore, A., Steerman, S.N. and Panneton, J.M. (2021) A Comparison of Stenting versus Hemodialysis Reliable Outflow Graft for Hemodialysis Patients with Recurrent Central Venous Obstructions. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 9, 1136-1144. [Google Scholar] [CrossRef] [PubMed]
[25] Tian, R., Zhu, H., Liu, L., et al. (2019) Clinical Observation for NAPD Regimen in the Treatment of 67 Cases of Recurrent Refractory Non-Hodgkin’s Lymphoma. Journal of Central South University. Medical Sciences, 44, 46-52.
[26] Agarwal, A.K. (2015) Endovascular Interventions for Central Vein Stenosis. Kidney Research and Clinical Practice, 34, 228-232. [Google Scholar] [CrossRef] [PubMed]
[27] Rockholt, M.M., Naddi, L., Badri, A.M., Englund, E. and Kander, T. (2024) Macro-and Microscopic Changes in Veins with Short-Term Central Venous Catheters: An Observational Autopsy Study. BMC Anesthesiology, 24, Article No. 5. [Google Scholar] [CrossRef] [PubMed]
[28] Davidson, C.J., Newman, G.E., Sheikh, K.H., Kisslo, K., Stack, R.S. and Schwab, S.J. (1991) Mechanisms of Angioplasty in Hemodialysis Fistula Stenoses Evaluated by Intravascular Ultrasound. Kidney International, 40, 91-95. [Google Scholar] [CrossRef] [PubMed]
[29] Kitrou, P.M., Papadimatos, P., Spiliopoulos, S., Katsanos, K., Christeas, N., Brountzos, E., et al. (2017) Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial. Journal of Vascular and Interventional Radiology, 28, 811-817. [Google Scholar] [CrossRef] [PubMed]
[30] Nayarisseri, A., Khandelwal, R., Tanwar, P., et al. (2021) Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery. Current Drug Targets, 22, 631-655. [Google Scholar] [CrossRef